Institutional Ownership
Dexcom Inc
CUSIP 252131107COMDXCMQ1 2026
Latest EPS (Diluted)
$0.64
Q2 2026 · Jun 30, 2026
Latest Revenue
$1.31B
Reported quarter
Latest Net Income
$249.10M
Reported quarter
Quarters on Record
12
From SEC XBRL filings
Quarterly Earnings
EPS, revenue & net income · SEC XBRL (10-Q / 10-K)
| Period | Quarter | EPS (Basic) | EPS (Diluted) | Revenue | Net Income | Form |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | Q2 2026 | $0.65 | $0.64 | $1.31B | $249.10M | 10-Q |
| Mar 31, 2026 | Q1 2026 | $0.52 | $0.51 | $1.19B | $199.50M | 10-Q |
| Sep 30, 2025 | Q3 2025 | $0.73 | $0.70 | $1.21B | $283.80M | 10-Q |
| Jun 30, 2025 | Q2 2025 | $0.46 | $0.45 | $1.16B | $179.80M | 10-Q |
| Mar 31, 2025 | Q1 2025 | $0.27 | $0.27 | $1.04B | $105.40M | 10-Q |
| Sep 30, 2024 | Q3 2024 | $0.34 | $0.34 | $994.20M | $134.60M | 10-Q |
| Jun 30, 2024 | Q2 2024 | $0.36 | $0.35 | $1.00B | $143.50M | 10-Q |
| Mar 31, 2024 | Q1 2024 | $0.38 | $0.36 | $921.00M | $146.40M | 10-Q |
| Sep 30, 2023 | Q3 2023 | $0.31 | $0.29 | $975.00M | $120.70M | 10-Q |
| Jun 30, 2023 | Q2 2023 | $0.30 | $0.28 | $871.30M | $115.90M | 10-Q |
| Mar 31, 2023 | Q1 2023 | $0.13 | $0.12 | $741.50M | $48.60M | 10-Q |
| Sep 30, 2022 | Q3 2022 | $0.26 | $0.24 | $769.60M | $101.20M | 10-Q |